U.S. markets close in 2 hours 38 minutes
  • S&P 500

    4,171.70
    +59.20 (+1.44%)
     
  • Dow 30

    34,370.67
    +349.22 (+1.03%)
     
  • Nasdaq

    13,398.91
    +273.92 (+2.09%)
     
  • Russell 2000

    2,211.95
    +41.00 (+1.89%)
     
  • Crude Oil

    65.28
    +1.46 (+2.29%)
     
  • Gold

    1,838.90
    +14.90 (+0.82%)
     
  • Silver

    27.44
    +0.38 (+1.41%)
     
  • EUR/USD

    1.2140
    +0.0056 (+0.46%)
     
  • 10-Yr Bond

    1.6470
    -0.0210 (-1.26%)
     
  • GBP/USD

    1.4093
    +0.0042 (+0.30%)
     
  • USD/JPY

    109.4370
    +0.0030 (+0.00%)
     
  • BTC-USD

    50,783.59
    +2,148.27 (+4.42%)
     
  • CMC Crypto 200

    1,421.52
    +62.96 (+4.63%)
     
  • FTSE 100

    7,043.61
    +80.28 (+1.15%)
     
  • Nikkei 225

    28,084.47
    +636.46 (+2.32%)
     

Investing in Sleep Apnea Companies

Brian Feroldi, The Motley Fool
·32 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

In this episode of Industry Focus: Wildcard, join Motley Fool contributor Brian Feroldi and host Emily Flippen as they talk about three companies trying to treat sleep apnea: ResMed (NYSE: RMD), Inspire Medical (NYSE: INSP), and Vivos Therapeutics (NASDAQ: VVOS). To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. Today is Wednesday, March 24th, and I am your host, Emily Flippen.